Longjin Pharmaceutical(SZ:002750) 第一财经·2025-05-28 15:17Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have announced significant developments, including regulatory actions, acquisitions, capital increases, and stock listings, which may present investment opportunities and risks for investors [2]. Regulatory Actions - Jiaying Pharmaceutical is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws, having received a notice of case filing on May 28, 2025 [3]. - *ST Longjin has received a decision from the Shenzhen Stock Exchange to terminate its stock listing, effective June 27, 2025, due to its stock price being below 1 yuan for twenty consecutive trading days [11][12]. Mergers and Acquisitions - ST United plans to acquire 100% of Runtian Industrial through a combination of share issuance and cash payment, aiming to enhance its positioning in the cultural tourism consumption sector [4]. - Longgao Co. is undergoing a restructuring of its controlling shareholder, Longyan Investment Development Group, which will become a wholly-owned subsidiary of the newly established investment development group with a registered capital of 3 billion yuan [6]. Capital Increases - Sanyou Chemical's controlling shareholder plans to increase capital by 100 million yuan in its subsidiary, Sanyou Silicon Industry, through a private agreement, with no changes to the consolidation scope [7]. Stock Listings - Shantui Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [9]. - Hehe Information intends to issue H-shares and apply for a listing on the Hong Kong Stock Exchange to enhance its global strategy and brand recognition [10]. Share Buybacks and Increases - China Gold's controlling shareholder plans to increase its stake in the company by 168 million to 335 million yuan within 12 months [13]. - Taiji Industry intends to repurchase shares worth 100 million to 120 million yuan, with the repurchased shares to be canceled [14]. Major Contracts - China Energy Construction's subsidiary has won a coal power project contract worth approximately 14.586 billion yuan [15]. - ST Huaxi has signed a significant contract worth about 2.9 billion USD (approximately 20.84 billion yuan) for the restoration of a power plant in Iraq, which represents 80.38% of its latest audited revenue [16].